ITG(SH:600755)2021-04-22 16:00Financial Performance - The company's operating revenue for 2020 was RMB 351,088,945,884.64, representing a 61.02% increase compared to RMB 218,046,936,338.70 in 2019[23]. - The net profit attributable to shareholders of the listed company was RMB 2,612,026,632.43, an increase of 13.11% from RMB 2,309,300,382.69 in the previous year[23]. - The net profit attributable to the parent company was RMB 2,250,877,189.37, reflecting a significant increase of 37.41% from RMB 1,638,102,013.11 in 2019[23]. - The net profit attributable to shareholders after deducting non-recurring gains and losses for the reporting period is CNY 2,073,232,672.24, with a basic earnings per share of CNY 1.12, representing a 24.44% increase compared to CNY 0.90 in 2019[28][27]. - The weighted average return on equity increased to 14.41%, up by 1.74 percentage points from 12.67% in 2019[27]. - The company reported a quarterly revenue of CNY 124,856,747,054.12 in Q4 2020, showing a strong performance compared to CNY 50,590,196,733.65 in Q1 2020[30]. - The net profit attributable to shareholders in Q4 2020 was CNY 648,907,800.34, compared to CNY 525,152,610.01 in Q1 2020[30]. - The basic earnings per share for the year, after deducting non-recurring gains and losses, was CNY 0.93, which is a 75.47% increase from CNY 0.53 in 2019[27]. - The company's total operating revenue increased by 61.02% year-on-year, reaching CNY 351.09 billion[82]. - The operating costs rose by 62.90% year-on-year, totaling CNY 344.36 billion, primarily due to increased revenue[82]. Cash Dividend and Profit Distribution - The cash dividend distribution plan proposes a cash dividend of RMB 4.60 per 10 shares, totaling RMB 895,277,915.94, which corresponds to a cash dividend ratio of 34.28% for the year[6]. - The company plans to maintain its profit distribution ratio despite potential changes in total share capital due to various corporate actions[6]. - The company has established a cash dividend policy to distribute at least 30% of the net profit attributable to shareholders in the years 2021-2023, barring special circumstances[171]. - The company plans to distribute a cash dividend of RMB 4.60 per 10 shares for the year 2020, totaling RMB 895,277,915.94, which represents a cash dividend payout ratio of 34.28%[175]. - For the year 2019, the company distributed a cash dividend of RMB 2.30 per 10 shares, amounting to RMB 425,516,841.75, with a payout ratio of 25.92%[172]. - The company’s cash dividend for 2018 was RMB 2.70 per 10 shares, totaling RMB 490,397,592.33, with a payout ratio of 32.51%[176]. Assets and Liabilities - The total assets increased by 26.76% to CNY 113,415,874,138.65 at the end of 2020, compared to CNY 89,472,801,921.16 at the end of 2019[26]. - The total equity attributable to shareholders increased by 5.72% to CNY 26,190,610,270.53 at the end of 2020, compared to CNY 24,773,464,268.55 at the end of 2019[26]. - The company’s cash and cash equivalents increased by 85.60% to ¥12.44 billion, primarily due to pre-sale funds from real estate operations[102]. - The company’s total financial assets decreased from RMB 7,557,056,545.76 to RMB 6,128,934,374.51, with a total change of RMB -1,428,122,171.25, but positively impacted profits by RMB 546,585,733.03[39]. - The company reported a significant increase in minority interests by 219.01% to ¥8,672,006,791.60, accounting for 7.65% of total assets, due to increased joint venture projects[113]. Business Segments and Growth - The supply chain management business generated revenue of CNY 330.40 billion, growing by 62.38% year-on-year, with total import and export volume reaching USD 9.534 billion, a 25.16% increase[65]. - The real estate segment achieved operating revenue of CNY 13.742 billion and signed sales amounting to CNY 25.750 billion, with a sales area of 1.0175 million square meters[75]. - The financial services segment generated operating revenue of CNY 6.943 billion, receiving multiple awards for innovation and service excellence[76]. - The company is actively expanding into health technology, focusing on medical data, CRO, and third-party testing, aligning with national health strategies to enhance public health[49]. - The company is focusing on the supply chain management industry, anticipating high demand for bulk commodities and emphasizing the importance of maintaining supply chain stability and competitiveness[147]. Risk Management and Compliance - The company has described existing risks and corresponding countermeasures in the report[10]. - The company has built a comprehensive risk management system, ensuring dynamic credit monitoring and risk assessment across its operations[53]. - The company anticipates risks in supply chain management due to market competition and international trade complexities, but has a robust risk control system in place[164]. - The company has no violations of decision-making procedures for providing guarantees[8]. - The company has no non-operating fund occupation by controlling shareholders and their related parties[8]. Strategic Initiatives and Future Plans - The company aims to deepen the integration of digitalization with its supply chain management, leveraging technologies such as big data and cloud computing[57]. - The company plans to gradually exit the real estate sector, focusing resources on core businesses and strategic emerging industries[155]. - The strategic goal for the next five years includes a transformation driven by the "2+X" strategy, emphasizing supply chain management and financial services[153]. - The company is committed to developing the health technology sector as a new profit growth driver, combining investment and operational capabilities[161]. - The company plans to leverage digital technology to enhance supply chain operations and financial services[158]. Audit and Compliance - The audit report issued by the accounting firm was a standard unqualified opinion[5]. - The company has appointed Rongcheng Accounting Firm for auditing services, with a fee of 5.06 million RMB for the audit period[190]. - The company has not reported any significant accounting errors or changes that would affect its financial statements during the reporting period[190]. - There were no major litigation or arbitration matters during the reporting period[193].